Study backs genetic markers for early delivery risk :
This article was originally published in Clinica
Pregnant women carrying specific interleukin-1 (IL-1) gene variations could be three times more likely to deliver pre-term babies than those without the variations, according to a US team. The IL-1 genetic factors produced a significant risk for pre-term delivery, independent of other risk factors such as smoking and age, said Amy Murtha of Duke University in Durham, North Carolina, who presented the findings at the Society for Maternal-Fetal Medicine in Miami earlier this month. San Antonio, Texas-based Interleukin Genetics which develops tests based on genetic factors that regulate control points in the inflammatory processes, said the gene variations in the study have previously been linked with an exaggerated inflammatory response.
You may also be interested in...
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.